The 15 Questions Worth Asking Your Oncologist (That Actually Change Decisions)
Good questions improve outcomes by clarifying intent, sequence, and what evidence would change the plan. Group your questions for maximum impact.
MS
Dr. Motaz Shieban
Surgical oncologist and regenerative medicine specialist.
Key Takeaways
Good questions improve outcomes by clarifying intent, sequence, and what evidence would change the plan.
Group questions into diagnosis/staging, goals, options/sequence, risk/benefit, and follow-up.
Shared decision-making frameworks formalize this process and reduce regret.
Many consultations fail not because clinicians are careless, but because the conversation is unstructured. The simplest way to improve decision quality is to ask questions that force clarity.
Most patients walk into an oncology appointment with a single overwhelming question: "Am I going to be okay?" That is a natural human response. But it is not a question that produces useful information. The questions that actually change decisions are specific, structured, and designed to expose the logic behind the treatment plan. This article gives you fifteen of them, grouped into five categories that mirror how oncologists think.
Why structured questions matter
An oncology consultation typically lasts between fifteen and forty-five minutes. In that time, the clinician needs to communicate a diagnosis, explain staging, outline treatment options, discuss risks, and answer your concerns. That is an enormous amount of information compressed into a short window.
Without structure, the conversation drifts. Patients leave with a general sense of what was said but without the specific details needed to make informed decisions. They remember the emotional tone but not the reasoning.
Structured questions solve this problem. They force both sides of the conversation to address the issues that actually drive treatment decisions. They also signal to your clinician that you are engaged and want to participate in the decision-making process -- which, in turn, tends to produce more thorough explanations.
The difference between good and poor questions
A poor question is not a stupid question. It is simply one that does not produce actionable information. "Is this serious?" will almost always get a vague answer because seriousness depends on context. "What is the primary goal of treatment -- cure, durable control, or symptom relief?" forces a precise answer that changes everything downstream.
Good questions share three properties: they are specific enough to have a concrete answer, they relate to a decision point, and the answer changes what you do next.
A) Diagnosis and staging
What is the confirmed diagnosis, and how confident are we?
What is the stage, and what evidence supports it?
What are the most important missing data points?
What this means in practice
The diagnosis is the foundation. Everything else -- treatment selection, prognosis discussions, sequencing decisions -- depends on getting the diagnosis right. When you ask "how confident are we?", you are asking whether additional testing is needed before committing to a treatment plan.
questionsoncologistconsultationpreparation
Related Articles
Staging determines the extent of disease. It is not a single test but a composite picture built from imaging, pathology, and sometimes surgical findings. Asking what evidence supports the stage helps you understand whether the staging is complete or provisional.
The third question -- about missing data -- is one of the most powerful questions a patient can ask. It forces the clinician to acknowledge uncertainty. Sometimes the answer is "nothing -- we have everything we need." Other times, the answer reveals that a scan is pending, a biopsy result is outstanding, or a genetic test has not yet been ordered. Knowing what is missing helps you understand where the plan might change.
B) Goals and intent
What is the primary goal: cure, durable control, or symptom relief?
What trade-offs are we accepting?
What this means in practice
Treatment intent is the single most important concept in oncology that patients rarely ask about directly. A curative plan looks very different from a palliative one. The drugs may be the same, but the doses, duration, tolerance for side effects, and decision thresholds are all different.
When you ask about trade-offs, you are asking: what are we giving up to achieve this goal? In curative treatment, the trade-off is usually tolerating more aggressive side effects for a higher chance of long-term disease control. In palliative treatment, the trade-off is accepting that the disease will not be eliminated but that quality of life can be preserved or improved.
Understanding trade-offs prevents a common source of patient frustration: feeling that treatment is too aggressive or too conservative without understanding why.
C) Options and sequencing
What are the evidence-based options in my situation?
Why this sequence?
What would make you change the plan?
What this means in practice
Oncology is rarely a single-option field. For most diagnoses, there are multiple evidence-based approaches. Asking about all the options -- not just the recommended one -- gives you a map of the decision landscape. It also allows you to understand why one option was chosen over another.
Sequencing is often more important than the individual treatments themselves. Surgery before chemotherapy produces different outcomes than chemotherapy before surgery in many cancers. Asking "why this sequence?" reveals the strategic thinking behind the plan.
Question eight is perhaps the most sophisticated question on this list. By asking what would change the plan, you learn the decision triggers. If the answer is "if imaging shows progression after two cycles, we would switch to a second-line regimen," you now know exactly what to watch for and when. This question transforms you from a passive recipient of treatment into an active participant in monitoring.
D) Risks and benefits
What is the strongest benefit you expect -- and how will we measure it?
What are the top three risks?
What are the alternatives if the first plan fails?
What this means in practice
Patients often hear about benefits in vague terms: "this treatment works well," or "we see good responses." Asking for the strongest expected benefit and how it will be measured forces specificity. The answer might be "we expect a measurable reduction in tumor size on imaging at eight weeks" or "we expect symptom improvement within the first cycle."
Asking about the top three risks rather than "what are the side effects?" is deliberate. Every treatment has a long list of possible side effects. What you need to know are the risks that are most likely, most serious, or most relevant to your life. Three is a manageable number that keeps the conversation focused.
The alternatives question is your safety net. If the first plan does not work, knowing that there is a second-line and third-line option reduces anxiety and helps you plan ahead.
Common misconceptions about risks
Many patients believe that if their oncologist recommends a treatment, the benefits must clearly outweigh the risks. This is usually true, but not always by a wide margin. In some situations, the benefit is modest and the risks are significant. Understanding the magnitude of both -- not just that one outweighs the other -- is essential for informed consent.
Another common misconception is that side effects are inevitable. Many side effects can be managed, reduced, or prevented with supportive care. Asking about risk management is just as important as asking about the risks themselves.
E) Monitoring and follow-up
How will response be assessed?
What are the red flags that require urgent review?
What is the recovery plan?
What is the single most important next step this week?
What this means in practice
Monitoring is where treatment plans either succeed or fail in execution. Knowing how response will be assessed -- whether by imaging, blood tests, symptom tracking, or physical examination -- helps you understand the timeline and what to expect at each checkpoint.
The red flags question connects to patient safety. Every treatment carries specific warning signs that require urgent medical attention. Knowing these in advance can save your life. Do not leave the consultation without a clear list.
The recovery plan addresses what happens between treatments and after treatment ends. This includes supportive care, rehabilitation, psychological support, nutritional guidance, and return-to-activity timelines.
Question fifteen is the anchor. After a complex consultation, you may feel overwhelmed. Knowing the single most important thing to do this week gives you a concrete starting point and reduces decision paralysis.
How to use these questions
Bring them printed. Write down the answers. If answers are vague, ask for clarification. Strong teams welcome structured questions because they improve safety.
Before the consultation
Print this list or save it on your phone. Review it the night before. Cross out any questions that have already been answered in previous appointments. Add any questions specific to your situation. Bring a notebook or ask someone to take notes for you.
Consider bringing a trusted person to the consultation. A second pair of ears catches details that the patient, who is under emotional stress, may miss. This person can also help you review the answers afterward.
During the consultation
Do not try to ask all fifteen questions in rapid succession. Let the conversation flow naturally and use the questions as checkpoints. If the clinician covers a topic before you ask, check it off. If time runs short, prioritize the questions you have not yet addressed and ask which ones the clinician considers most important to answer today.
If an answer is unclear, say so. Phrases like "Can you explain that in simpler terms?" or "I want to make sure I understood -- are you saying...?" are not signs of weakness. They are signs of engagement.
After the consultation
Review your notes within twenty-four hours while the conversation is still fresh. Write down any follow-up questions that arise. If you realize you missed something important, call the clinic and ask. Most teams are happy to clarify by phone or secure message.
When to seek a second opinion
A second opinion is not a sign of distrust. It is a standard part of oncology care, particularly for complex or unusual diagnoses. Consider seeking one if the treatment plan is aggressive, the diagnosis is rare, or if the answers to these fifteen questions left you with significant uncertainty.
A good consultation gives you a plan and a logic. These questions are designed to extract the logic -- so you can participate intelligently in your own care.
Summary
The fifteen questions in this article are organized around the five pillars of oncology decision-making: diagnosis, goals, options, risks, and monitoring. They are not designed to challenge your clinician but to ensure that the conversation covers the ground that matters most. Patients who ask structured questions tend to feel more confident in their decisions, experience less regret, and engage more effectively with their treatment teams. Print the list, bring it to your next appointment, and use it as a framework for a conversation that could change the course of your care.
Educational content only. This article does not replace diagnosis, emergency care, or treatment by your local licensed clinicians.